Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...
As Pioneer marks 100 years, leaders say gene editing and advanced data tools are poised to drive the next leap in corn yield, building on a century of gains from hybrids, biotech and management ...
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with ...
A new highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...
HKTDC start-up development programme backs early-stage ventures with international ambitions, following a 2025 cohort led by healthtech, AI and green innovation ...
Learn more about whether Celldex Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
ATRIMED’s work is driven by a women-led leadership and research culture that emphasizes interdisciplinary collaboration and long-term scientific investment. From data curation to algorithm development ...
America’s adversaries are deploying every espionage tactic imaginable to gain diplomatic, military and technological ...
Artisan Global Discovery Fund achieved strong absolute returns in 2025 but trailed its index. Read the full analysis for more details.
Creative Biolabs announces upgraded downstream services designed to bridge the gap between raw antibody expression and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results